Hypertension and genome-wide association studies: Combining high fidelity phenotyping and hypercontrols

Journal of Hypertension

Volumn 26, Issue 7, 2008, Pages 1275-1281

  Padmanabhan, Sandosh ^a   Melander, Olle ^b   Hastie, Claire ^a   Menni, Cristina ^a   Delles, Christian ^a   Connell, John M ^a   Dominiczak, Anna F ^a,c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Genetics; Genome wide association; Hypertension; Polymorphism

Indexed keywords

ATTRIBUTABLE RISK; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; HYPERTENSION; LIFESTYLE; PHENOTYPE; POPULATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ARTICLE; CHROMOSOME MAP; GENETIC PREDISPOSITION; GENETICS; GENOME;

CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; GENOME; HUMANS; HYPERTENSION; LINKAGE (GENETICS); PHENOTYPE;

EID: 53649090543     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282ff634f     Document Type: Review

References (50)

1. Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet 2006; 7:829-840.
2. Guyton AC, Coleman TG, Cowley AW Jr, Liard JF, Norman RA Jr, Manning RD Jr. Systems analysis of arterial pressure regulation and hypertension. Ann Biomed Eng 1972; 1:254-281.
3. Carretero OA, Oparil S. Essential hypertension. Part I: Definition and etiology. Circulation 2000; 101:329-335.
4. Mongeau JG, Biron P, Sing CF. The influence of genetics and household environment upon the variability of normal blood pressure: the Montreal Adoption Survey. Clin Exp Hypertens A 1986; 8:653-660.
5. Feinleib M, Garrison RJ, Fabsitz R, Christian JC, Hrubec Z, Borhani NO, et al. The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am J Epidemiol 1977; 106:284-285.
6. Neel JV. Diabetes mellitus: a 'thrifty' genotype rendered detrimental by ''progress''? Am J Hum Genet 1962; 14:353-362.
7. Weder AB. Evolution and hypertension. Hypertension 2007; 49:260-265.
8. Nakajima T, Wooding S, Sakagami T, Emi M, Tokunaga K, Tamiya G, et al. Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet 2004; 74:898 -916.
9. Young JH, Chang YP, Kim JD, Chretien JP, Klag MJ, Levine MA, et al. Differential susceptibility to hypertension is due to selection during the out-of-Africa expansion. PLoS Genet 2005; 1:e82.
10. Brunner HR, Gavras H. Is the renin system necessary? Am J Med 1980; 69:739-745.
11. Lifton RP. Genetic dissection of human blood pressure variation: common pathways from rare phenotypes. HarveyLect 2004; 100:71 -101.
12. Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, Farrall M, et al. Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics ofHypertension study. Hum Mol Genet 2005; 14:1805-1814.
13. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293:1107-1112.
14. Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, et al. Genome-wide mapping of human loci for essential hypertension. Lancet 2003; 361:2118 -2123.
15. Padmanabhan S, Wallace C, Munroe PB, Dobson R, Brown M, Samani N, et al. Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study. Hypertension 2006; 47:603-608.
16. Koivukoski L, Fisher SA, Kanninen T, Lewis CM, von Wowern F, Hunt S, et al. Meta-analysis of genome-wide scans for hypertension and blood pressure in Caucasians shows evidence of susceptibility regions on chromosomes 2 and 3. Hum Mol Genet 2004; 13:2325-2332.
17. Gu CC, Hunt SC, Kardia S, Turner ST, Chakravarti A, Schork N, et al. An investigation of genome-wide associations of hypertension with microsatellite markers in the family blood pressure program (FBPP). Hum Genet 2007; 121:577 -590.
18. Wu X, Kan D, Province M, Quertermous T, Rao DC, Chang C, et al. An updated meta-analysis of genome scans for hypertension and blood pressure in the NHLBI Family Blood Pressure Program (FBPP). Am J Hypertens 2006; 19:122 -127.
19. Dominiczak AF, Graham D, McBride MW, Brain NJ, Lee WK, Charchar FJ, et al. Corcoran Lecture. Cardiovascular genomics and oxidative stress. Hypertension 2005; 45:636-642.
20. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001; 17:502 -510.
21. Wang WY, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005; 6:109-118.
22. Wright AF, Hastie ND. Complex genetic diseases: controversy over the Croesus code. Genome Biol 2001; 2:comment2007.1-comment2007.8.
23. Morton NE. Significance levels in complex inheritance. Am J Hum Genet 1998; 62:690-697.
24. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3 000 shared controls. Nature 2007; 447:661 -78.
25. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316:889-894.
26. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, etal. Acommon varianton chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316:1491 -1493.
27. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007; 316:1331-1336.
28. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007; 316:1341-1345.
29. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, et al. Replication of genome-wide association signals in U.K. samples reveals risk loci for type 2 diabetes. Science 2007; 316:1336- 1341.
30. Lander ES. The new genomics: global views of biology. Science 1996; 274:536-539.
31. Marth G, Schuler G, Yeh R, Davenport R, Agarwala R, Church D, et al. Sequence variations in the public human genome data reflect a bottlenecked population history. Proc Natl Acad Sci U S A 2003; 100:376-381.
32. Wright S. Evolution and the genetics of populations. Vol. 1: Genetic and biometric foundations. Chicago: University of Chicago Press; 1968.
33. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001; 69:124-137.
34. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005; 6:95-108.
35. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449:851 -861.
36. The International HapMap Project. Nature 2003; 426:789-96.
37. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273:1516 -1517.
38. Jorgenson E, Witte JS. A gene-centric approach to genome-wide association studies. Nat Rev Genet 2006; 7:885-891.
39. Doris PA. Hypertension genetics, single nucleotide polymorphisms, and the common disease:common variant hypothesis. Hypertension 2002; 39:323-331.
40. Farrall M, Morris AP. Gearing up for genome-wide gene-association studies. Hum Mol Genet 2005; 14 (Suppl 2):R157-R162.
41. Newton-Cheh C, Hirschhorn JN. Genetic association studies of complex traits: design and analysis issues. Mutat Res 2005; 573:54-69.
42. Clerget-Darpoux F, Elston RC. Are linkage analysis and the collection of family data dead? Prospects for family studies in the age of genome-wide association. Hum Hered 2007; 64:91-96.
43. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet 2004; 5:89-100.
44. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiologystudies. J Natl Cancer Inst 2004; 96:434-442.
45. Culverhouse RC, Suarez BK, Beckmann L, Chen P, Chen YS, Chiu YF, et al. Gene by environment interactions. Genet Epidemiol 2007; 31 (Suppl 1):S68-S74.
46. Hein R, Beckmann L, Chang-Claude J. Sample size requirements for indirect association studies of gene-environment interactions (G x E). Genet Epidemiol 2008; 32:235-245.
47. Kooperberg C, Leblanc M. Increasing the power ofidentifying gene x gene interactions in genome-wide association studies. Genet Epidemiol 2008; 32:255-263.
48. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, et al. Replicating genotype-phenotype associations. Nature 2007; 447:655-660.
49. Ioannidis JP, Patsopoulos NA, Evangelou E. Heterogeneity in meta- analyses of genome-wide association investigations. PLoS ONE 2007; 2:e841.
50. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. Global variation in copynumber in the human genome. Nature 2006; 444:444-454.